Umbilical cord blood transplantation

Cancer Treatment and Research

Volumn 144, Issue , 2009, Pages 233-255

  Wagner, John E ^a   Brunstein, Claudio ^b   Tse, William ^b   Laughlin, Mary ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ALGORITHM; BETA THALASSEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; GRAFT SURVIVAL; HEMOGLOBINOPATHY; HLA MATCHING; HUMAN; HURLER SYNDROME; IMMUNE DEFICIENCY; METABOLIC DISORDER; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SIBLING; SICKLE CELL ANEMIA; UMBILICAL CORD BLOOD;

EID: 77953655148     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78580-6_10     Document Type: Review

References (68)

1. Ende M, Ende N. Hematopoietic transplantation by means of fetal (cord) blood. Va Med J. 1972;99:276-280
2. Koike K. Cryopreservation of pluripotent and committed hemopoietic progenitor cells from human bone marrow and cord blood. Acta Paediatr Jpn. 1983;25:275.
3. Vidal JB. Nature and characterization of granulocyte-macrophage precursors in cord blood. Universtiy of Valencia School of Medicine (Doctoral Dissertation); 1985.
4. Broxmeyer HE, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA. 1989;86:3828-3832
5. Broxmeyer HE, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA. 1992;89:4109-4113
6. Gluckman E, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174-1178
7. Cardoso AA, et al. Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA. 1993;90:8707-8711
8. Yahata T, et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003;101:2905-2913
9. Broxmeyer HE. Introduction: The past, present, and future of cord blood transplantation. In: Broxmeyer HE, editor. Cellular characteristics of cord blood and cord blood transplantation. Bethesda, MA: AABB Press; 1998. p. 1-9.
10. Hannet I, et al. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today. 1992;13:215, 218.
11. Rainaut M, et al. Characterization of mononuclear cell subpopulations in normal fetal peripheral blood. Hum Immunol. 1987;18:331-337
12. Clement LT, Vink PE, Bradley GE. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate. J Immunol. 1990;145:102-108
13. Godfrey WR, et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005;105:750-758
14. Cohen JL, et al. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graftversus- host disease. J Exp Med. 2002;196:401-406
15. Hoffmann P, et al. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389-399
16. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002;99:3493-3499
17. Taylor PA, et al. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GvHD and BM graft rejection. Blood 2004;104:3804-3812
18. Trenado A, et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest. 2003;112:1688-1696
19. Wagner JE, et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995;346:214-219
20. Wagner JE, Kurtzberg J. Allogeneic umbilical cord blood transplantation. In: Broxmeyer HE, editor. Cellular characteristics of cord blood and cord blood transplantation. Bethesda, MA: AABB Press; 1998. p. 113-146
21. Gluckman E, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337:373-381
22. Rocha V, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342:1846-1854
23. Kurtzberg J, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157-166
24. Wagner JE, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graftversus- host disease. Blood 1996;88:795-802.
25. Rubinstein P, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577
26. Gluckman E, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32:397-407.
27. Rubinstein P, Stevens CE. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. Baillieres Best Pract Res Clin Haematol. 2000;13:565-584
28. Wagner JE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-1618
29. Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D, Wagner JE, Kurtzberg J. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant. 2006 Feb;12(2):184-194
30. Laporte JP, et al. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia. N Engl J Med. 1996;335:167-170
31. Laughlin MJ, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815-1822
32. Rocha V, et al. Prognostic factors of outcome after unrelated cord blood transplant (UCBT) in adults with hematologic malignancies. Blood 2000;96:587a.
33. Sanz GF, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001;98:2332-2338
34. Laporte JP, et al. Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience. Bone Marrow Transplant. 1998;22 Suppl 1:S76-s77.
35. Arcese W, et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica 2006;91:223-230
36. Cornetta K, et al. Umbilical cord blood transplantation in adults: results of the prospective cord blood transplantation (COBLT). Biol Blood Marrow Transplant. 2005;11:149-160
37. Iori AP, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. Bone Marrow Transplant. 2004;33:1097-1105
38. Long GD, et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant. 2003;9:772-780
39. Ooi J, et al. Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia. Br J Haematol. 2001;114:834-836
40. Tomonari A, et al. Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation. Eur J Haematol. 2006;77:46-50.
41. Barker JN, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005;105:1343-1347
42. Konuma T, et al. Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years. Bone Marrow Transplant. 2006;37:803-804
43. Ooi J, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004;103:489-491 (Pubitemid 38140078)
44. Kai S, et al. Double-unit cord blood transplantation in Japan. Blood 2004;104:5166a.
45. Ooi J. The efficacy of unrelated cord blood transplantation for adult myelodysplastic syndrome. Leuk Lymphoma. 2006;47:599-602. (Pubitemid 43753369)
46. Barker JN, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001;97:2957-2961
47. Eapen M, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007;369:1947-1954
48. Meyer EA, et al. Cord blood: establishing a national cord blood stem cell bank program. Washington: The National Academy Press; 2005.
49. Adamkiewicz TV, et al. Unrelated cord blood transplantation in children with sickle cell disease: US centers experience. Blood 2005;106:2044.
50. Fang J, et al. Umbilical cord blood transplantation in Chinese children with betathalassemia. J Pediatr Hematol Oncol. 2004;26:185-189
51. Jaing TH, et al. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biol Blood Marrow Transplant. 2005;11:349-353
52. Locatelli F, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101:2137-2143
53. Miniero R, et al. Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord. Bone Marrow Transplant. 1998;22 Suppl 1:S78-9.
54. Walters MC, et al. Sibling donor cord blood transplantation for thalassemia major: experience of the sibling donor cord blood program. Ann N Y Acad Sci. 2005;1054:206-213
55. Martin PL, et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant. 2006;12:184-194
56. Escolar ML, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005;352:2069-2081
57. Staba SL, et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med. 2004;350:1960-1969
58. Rocha V, et al. Results of unrelated cord blood versus unrelated bone marrow transplant in adults with acute leukemia. A matched pair analysis. Blood 2002;100:42a.
59. Laughlin MJ, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265-2275
60. Takahashi S, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004;104:3813-3820
61. Hwang WY, et al. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant. 2007;13:444-453
62. Rocha V, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276-2285
63. van Heeckeren WJ, et al. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. Br J Haematol. 2007;139:464-474
64. Brunstein CG, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplant outcomes in 110 adults with hematological disease. Blood 2007;110(8):3064-3070
65. Brunstein CG, Wagner JE. Cord blood transplantation for adults. Vox Sang. 2006;91:195-205.
66. Majhail NS, Brunstein CG, Wagner JE. Double umbilical cord blood transplantation. Curr Opin Immunol. 2006;18:571-575
67. Rocha V, et al. Reduced intensity conditioning regimen in single unrelated cord blood transplantation in adults with hematological malignant disorders. An Eurocord-Netcord and SFGM-TC survey. Blood 2006;108:897a.
68. Hamza NS, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol. 2004;124:488-498